Abstract

Background: Vector velocity imaging (VVI) is a two-dimensional wall motion tracking method that can measure cardiac mechanics in hypertrophic cardiomyopathy (HCM). 3D-speckle tracking echocardiography (3D-STE) has been proven to be superior to conventional measures in assessment of LV function. The aim of this study was to compare the two technologies in the assessment of LV longitudinal strain (LS) in HCM patients.Methods: A total of 50 patients with HCM were investigated using VVI and 3D-STE in same setting. 3D-STE allows obtaining longitudinal, circumferential, radial and area strains (AS). Values of longitudinal strain (LS) and AS by 3D-STE were compared to VVI- derived analyses. Thereafter, VVI-LS values were correlated with LV phenotype. Last, the variability of VVI versus 3DE strain measurements as well as recorded time of analysis was assessed.Results: The absolute value of 3D-STE LS and AS is significantly higher than VVI-LS (P < 0.0001). VVI provided complete longitudinal LV strain information, similar to 3D-STE. There is excellent agreement between the two technologies-derived values, however, a greater number of segments could be analyzed using VVI (94.7%), compared with 3DE (62.1%). Despite VVI being more time consuming, VVI-LS is more correlated to LV mass index, mitral regurgitation severity and functional class when compared with 3D-STE LS and AS.Conclusions: VVI is a feasible modality for assessing LV longitudinal strain. Although VVI agreed well with 3D-STE for most of regional and global LS, a better correlation was found between VVI-LS and HCM phenotype. It is hypothesized that this discrepancy originates from the inferior imaging quality using 3D tracking algorithms.

Highlights

  • LV ejection fraction (LVEF) is the most popular index of myocardial systolic function

  • The primary objectives of this study were to compare Vector velocity imaging (VVI) longitudinal strain measurements derived from 2DE against those derived from 3D-speckle tracking echocardiography (3D-STE), performed in patients with Hypertrophic cardiomyopathy (HCM) who underwent both studies on the same day, and to evaluate the usefulness of each method to reflect the underlying pathology in such complex disease

  • We have demonstrated that the application of VVI to measure LV longitudinal strain is both feasible and reproducible, providing excellent agreement with values derived from three-dimensional echocardiography in patients with HCM

Read more

Summary

Introduction

LV ejection fraction (LVEF) is the most popular index of myocardial systolic function. A new feature-tracking echocardiographic method using velocity vector imaging (VVI) is applied through a combination of mitral annulus motion, tissue-blood border detection, and speckle tracking. It has previously been validated against crystal sonomicrometry[7], providing an angle-independent principle of myocardial deformation[8,9]. Vector velocity imaging (VVI) is a two-dimensional wall motion tracking method that can measure cardiac mechanics in hypertrophic cardiomyopathy (HCM). Despite VVI being more time consuming, VVI-LS is more correlated to LV mass index, mitral regurgitation severity and functional class when compared with 3D-STE LS and AS. It is hypothesized that this discrepancy originates from the inferior imaging quality using 3D tracking algorithms

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call